Alembic Limited

BSE: 506235 NSE: ALEMBICLTD
Alembic Limited - pharma in Baroda, Gujarat, India. FY 2026 financials and compliance.
CIN L26100GJ1907PLC000033 Incorporated 30 July 1907 ROC Ahmedabad HQ Baroda, Gujarat, India
Active Listed - NSE: ALEMBICLTD · BSE: 506235 Public Limited Company pharma
Data last updated
Revenue · FY 2026
₹239.99 Cr
▲ 8.16% YoY
Computed EBITDA · FY 2026
₹163.43 Cr
▼ 3.07% YoY
Net profit · FY 2026
₹317.38 Cr
▲ 2.16% YoY
Authorised capital
₹60 Cr
Registered with MCA
Paid-up capital
₹51.36 Cr
Issued & subscribed
Open charges
₹67 Cr
Satisfied ₹446.2 Cr
Company age
119 yrs
Est. 1907
Employees · EPFO
287
Latest available

About Alembic Limited

Data last updated: 14 July 2026

Alembic Limited is a public limited company based in Baroda, Gujarat, India, a subsidiary of Nirayu Limited. It specialises in api manufacturers, a part of the broader pharmaceuticals sector. Incorporated on 30 July 1907, the company has been in operation for over 119 years.

Registered with ROC Ahmedabad under CIN L26100GJ1907PLC000033. Listed on BSE: 506235 and NSE: ALEMBICLTD.

Capital: an authorised share capital of ₹60 Cr and a paid-up capital of ₹51.36 Cr. Formerly known as Alembic Chemical Works Co Ltd. It is led by directors including Rati Desai and Chirayu Ramanbhai Amin.

Last AGM: 12 August 2025. Financial statements filed for year ended 31 March 2025. Office: Alembic Road, Baroda, Gujarat, India – 390003.

As per NSE-filed consolidated financials for FY 2026, the company reported a revenue of ₹239.99 Cr, a growth of 8.16% compared to the previous year. The net worth stands at ₹2,445.09 Cr (up 4.55% YoY). Total assets are valued at ₹2,589.51 Cr (up 3.46% YoY).

The company has a workforce of approximately 287 employees as per the latest available data. It operates as a subsidiary of Nirayu Limited. Its group structure includes 1 subsidiary.

The company is associated with 1 brand - Alembic Limited. As per MCA filings, the company has open charges of ₹67 Cr and satisfied charges of ₹446.2 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website alembiclimited.com.

Company Details of Alembic Limited
CIN L26100GJ1907PLC000033
Registration Number 000033
Incorporation Date 30 July 1907
ROC Ahmedabad
Listing Status Listed (BSE: 506235, NSE: ALEMBICLTD)
Company Status Active
Date of Last AGM 12 August 2025
Date of Balance Sheet 31 March 2025
Parent Company Nirayu Limited
Compliance Status Active Compliant
Key People
Udit Chirayu Amin Managing Director Rati Desai Director Chirayu Ramanbhai Amin Director
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    alembiclimited.com
  • Social Media
    Locked
  • Registered Address
    Alembic Road, Baroda, Gujarat, India – 390003
  • Industry
    Pharma, API Manufacturers
Company report
Alembic Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Alembic Limited report

Financials, compliance, directors, charges, ownership and filings for Alembic Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Alembic Limited

Alembic Limited has one previous CIN (Corporate Identification Number): U26100GJ1907PLC000033. The current CIN is L26100GJ1907PLC000033, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
L26100GJ1907PLC000033 Current
U26100GJ1907PLC000033 Previous

Associated Brands with Alembic Limited

Alembic Limited operates one associated brand: Alembic Limited. These brands represent Alembic Limited's diversified market presence and brand portfolio.

Brand Description Website
Alembic Limited
Active pharmaceutical ingredients are manufactured by Alembic. alembiclimited.com

Competitors & Alternatives of Alembic Limited

Brands and companies operating in the same space as Alembic Limited include Merck, Roivant Sciences, AbbVie and 7 more.

Competitor Description Location Founded
Merck Merck Pharmaceutical products are manufactured and marketed worldwide. Kenilworth, United Kingdom, United Kingdom 1891
Roivant Sciences Roivant Sciences Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. New York, United States, United States 2014
AbbVie AbbVie Biopharmaceutical research and drug development are conducted globally by AbbVie. Chicago, United States, United States 2012
Lilly Lilly Traditional pharmaceutical medicines are developed for multiple health fields. United States 1876
Gilead Gilead Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others Foster City, United States, United States 1987
United Therapeutics United Therapeutics Treatments for chronic and life-threatening diseases are developed and commercialized. Silver Spring, United States, United States 1998
Roche Roche Pharmaceuticals and diagnostics kits are developed for various diseases. Basel, Switzerland, Switzerland 1896
Ascendis Pharma Ascendis Pharma Long-acting prodrug therapies are developed for endocrine and rare diseases. Hellerup, Denmark, Denmark 2007
MorphoSys MorphoSys Therapeutic antibodies for cancer and other diseases are developed. Planegg, Germany, Germany 1992
Vertex Pharmaceuticals Vertex Pharmaceuticals Developer of drugs for the treatment of multiple disorders United States 1989

Business Activity of Alembic Limited

Alembic Limited is engaged in principal business activities including manufacturing and real estate, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products, real estate activities with own or leased property. The company has 2 registered principal business activity segments, demonstrating its operational diversity and market reach.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
L Real Estate L1 Real estate activities with own or leased property Locked
Premium access

Business activity turnover details for Alembic Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Alembic Limited

Alembic Limited is audited by CNK & ASSOCIATES LLP (ICAI peer reviewed, certificate valid till 2026-07-31) for the financial year 2026, as reported in its NSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.

Name Financial year Audit opinion
CNK & ASSOCIATES LLP (ICAI peer reviewed, certificate valid till 2026-07-31) FY 2026 Declaration of unmodified opinion

Board of Directors of Alembic Limited

Alembic Limited is currently managed by 8 directors, with 20 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Rati Desai
Also directs: Alembic Limited, Shiva Pharmachem Limited, Alembic City Limited
Director 13 Aug 2019 6 Years 11 Months Current
Chirayu Ramanbhai Amin
Also directs: Alembic Limited, Alembic Pharmaceuticals Limited, Paushak Limited and 4 more
Director 20 Aug 1967 58 Years 11 Months Current
Malika Chirayu Amin
Also directs: Alembic Limited, Whispering Mist Estate And Infra Private Limited, Eleventa Properties Private Limited and 4 more
Director 02 Jul 1988 38 Years 1 Months Current
Udit Chirayu Amin
Also directs: Alembic Limited, Paushak Limited, Shreno Limited and 2 more
Managing Director 28 Mar 2016 10 Years 4 Months Current
Sanjeev Virendra Shah
Also directs: Alembic Limited, Sterling Ferro Alloys Pvt Ltd
Director 07 Feb 2025 1 Years 6 Months Current
Mayurdhvaj Dilipsinh Jadeja
Also directs: Alembic Limited, Ratna Nico Chem Pvt Ltd
Director 07 Feb 2025 1 Years 6 Months Current
Showing 6 of 8 current directors. View all directors

Financials of Alembic Limited FY 2026 filings available

Alembic Limited reported revenue of ₹239.99 Cr (up 8.16% YoY) for FY 2026.

Revenue · FY 2026
₹239.99 Cr ▲ 8.16%
Profit · FY 2026
₹317.38 Cr ▲ 2.16%
Computed EBITDA · FY 2026
₹163.43 Cr ▼ 3.07%
Revenue₹ Cr · Consolidated0100200300FY 2020: ₹74 Cr73.9FY 2020FY 2021: ₹74 Cr · -0.6% YoY73.5-0.6%FY 2021FY 2022: ₹78 Cr · +6.4% YoY78.2+6.4%FY 2022FY 2023: ₹127 Cr · +62.7% YoY127+62.7%FY 2023FY 2024: ₹157 Cr · +23.8% YoY157+23.8%FY 2024FY 2025: ₹222 Cr · +40.9% YoY222+40.9%FY 2025FY 2026: ₹240 Cr · +8.2% YoY240+8.2%FY 2026
Net Profit₹ Cr · Consolidated0200400FY 2020: ₹329 Cr329FY 2020FY 2021: ₹343 Cr · +4.2% YoY343+4.2%FY 2021FY 2022: ₹222 Cr · -35.2% YoY222-35.2%FY 2022FY 2023: ₹191 Cr · -14.1% YoY191-14.1%FY 2023FY 2024: ₹269 Cr · +40.9% YoY269+40.9%FY 2024FY 2025: ₹311 Cr · +15.7% YoY311+15.7%FY 2025FY 2026: ₹317 Cr · +2.2% YoY317+2.2%FY 2026
Quarterly Revenue₹ Cr · vs same quarter last year0255075Q1'25: ₹51 Cr · +37.9% YoY50.8+37.9%Q1'25Q2'25: ₹53 Cr · +63.9% YoY52.9+63.9%Q2'25Q3'25: ₹58 Cr · +47.3% YoY57.9+47.3%Q3'25Q4'25: ₹60 Cr · +22.9% YoY60.3+22.9%Q4'25Q1'26: ₹50 Cr · -2% YoY49.7-2%Q1'26Q2'26: ₹56 Cr · +5.6% YoY55.9+5.6%Q2'26Q3'26: ₹74 Cr · +28.3% YoY74.3+28.3%Q3'26Q4'26: ₹60 Cr · -0.4% YoY60-0.4%Q4'26
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Revenue from Operations ₹239.99 Cr ₹221.89 Cr ₹157.49 Cr ₹127.24 Cr ₹78.22 Cr ₹73.52 Cr ₹73.93 Cr
Other Income ₹72.97 Cr ₹74.89 Cr ₹54.77 Cr ₹64.26 Cr ₹89.18 Cr ₹10.27 Cr ₹93.4 Cr
Total Income ₹312.96 Cr ₹296.78 Cr ₹212.26 Cr ₹191.51 Cr ₹167.4 Cr ₹83.79 Cr ₹167.33 Cr
Cost of Materials Consumed ₹13.88 Cr ₹8 Cr ₹8.62 Cr ₹6.92 Cr ₹8.53 Cr ₹11.77 Cr ₹24.59 Cr
Purchases of Stock-in-Trade ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Changes in Inventories ₹2.55 Cr ₹1.11 Cr ₹52.52 Lakh -₹60.18 Lakh ₹2.46 Cr -₹2.39 Cr ₹6.84 Cr
Employee Benefit Expense ₹37.44 Cr ₹27.31 Cr ₹23.03 Cr ₹24.04 Cr ₹21.47 Cr ₹22.6 Cr ₹20.79 Cr
Finance Costs ₹2.28 Cr ₹2.47 Cr ₹1.11 Cr ₹46.54 Lakh ₹38.91 Lakh ₹36.2 Lakh ₹28.8 Lakh
Depreciation & Amortisation ₹12.39 Cr ₹10.63 Cr ₹7.84 Cr ₹6.72 Cr ₹4.86 Cr ₹3.94 Cr ₹3.23 Cr
Other Expenses ₹95.66 Cr ₹91.75 Cr ₹68.45 Cr ₹56.55 Cr ₹31.83 Cr ₹30.47 Cr ₹18.43 Cr
Total Expenses ₹164.2 Cr ₹141.28 Cr ₹109.57 Cr ₹94.1 Cr ₹69.54 Cr ₹66.75 Cr ₹74.16 Cr
Profit Before Exceptional Items & Tax ₹148.76 Cr ₹155.5 Cr ₹102.69 Cr ₹97.41 Cr ₹97.86 Cr ₹17.04 Cr ₹93.17 Cr
Exceptional Items ₹0 ₹0 ₹0 -₹10.61 Cr ₹0 ₹0 ₹0
Profit Before Tax ₹148.76 Cr ₹155.5 Cr ₹102.69 Cr ₹86.8 Cr ₹97.86 Cr ₹17.04 Cr ₹93.17 Cr
Total Tax Expense ₹22.83 Cr ₹10.93 Cr ₹9.82 Cr ₹6.18 Cr ₹11.66 Cr ₹3.2 Cr ₹13.09 Lakh
Net Profit ₹317.38 Cr ₹310.68 Cr ₹268.62 Cr ₹190.65 Cr ₹222.06 Cr ₹342.84 Cr ₹329.12 Cr
  attributable to Owners ₹229.83 Cr ₹310.68 Cr ₹268.62 Cr ₹190.65 Cr ₹222.06 Cr ₹342.84 Cr ₹329.12 Cr
  attributable to NCI ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Other Comprehensive Income -₹87.55 Cr -₹34.32 Cr -₹59.72 Cr -₹214.11 Cr ₹106.85 Cr ₹344.65 Cr -₹17.21 Cr
Total Comprehensive Income ₹229.83 Cr ₹276.36 Cr ₹208.9 Cr -₹23.46 Cr ₹328.91 Cr ₹687.49 Cr ₹311.9 Cr
EBITDA (computed) ₹163.43 Cr ₹168.6 Cr ₹111.63 Cr ₹104.6 Cr ₹103.11 Cr ₹21.34 Cr ₹96.68 Cr
Basic EPS ₹12.36 ₹12.10 ₹10.46 ₹7.43 ₹8.65 ₹13.35 ₹12.82
Diluted EPS ₹12.36 ₹12.10 ₹10.46 ₹7.43 ₹8.65 ₹0.00 ₹12.82
Metrics FY 2026 FY 2025 FY 2024 FY 2023
Total Assets ₹2,589.51 Cr ₹2,503 Cr ₹2,328.77 Cr ₹2,204.58 Cr
Non-current Assets ₹2,392.27 Cr ₹2,298.14 Cr ₹2,191.38 Cr ₹2,032.45 Cr
Current Assets ₹197.24 Cr ₹204.87 Cr ₹137.39 Cr ₹172.14 Cr
Property, Plant & Equipment ₹169.95 Cr ₹135.33 Cr ₹130.54 Cr ₹131.83 Cr
Inventories ₹52.24 Cr ₹99.39 Cr ₹92.6 Cr ₹88.61 Cr
Trade Receivables ₹31.9 Cr ₹29.97 Cr ₹19.76 Cr ₹23.45 Cr
Cash & Equivalents ₹1.41 Cr ₹2.71 Cr ₹1.26 Cr ₹93.18 Lakh
Equity (Net Worth) ₹2,445.09 Cr ₹2,338.59 Cr ₹2,185.56 Cr ₹2,078.03 Cr
Equity Share Capital ₹51.36 Cr ₹51.36 Cr ₹51.36 Cr ₹51.36 Cr
Borrowings (Non-current) ₹6.61 Cr ₹10.67 Cr ₹7.39 Cr ₹0
Borrowings (Current) ₹4.03 Cr ₹3.78 Cr ₹1.76 Cr ₹0
Total Debt (computed) ₹10.64 Cr ₹14.45 Cr ₹9.15 Cr ₹0
Current Liabilities ₹101.3 Cr ₹110.47 Cr ₹90.32 Cr ₹83.81 Cr
Total Liabilities ₹144.42 Cr ₹164.41 Cr ₹143.21 Cr ₹126.55 Cr
The balance sheet became part of the exchange results-filing format in FY2023 - earlier years were not filed and are hidden.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow ₹120.07 Cr ₹86.37 Cr ₹22.69 Cr ₹38.85 Cr -₹17.75 Cr
Investing Cash Flow -₹53.86 Cr -₹26.58 Cr ₹25.84 Cr ₹7.3 Cr ₹18.85 Cr
Financing Cash Flow -₹67.5 Cr -₹58.34 Cr -₹48.19 Cr -₹46.39 Cr -₹5.82 Cr
Capital Expenditure ₹38.25 Cr ₹6.58 Cr ₹1.39 Cr ₹4.68 Lakh ₹1.02 Cr
Free Cash Flow (computed) ₹81.82 Cr ₹79.79 Cr ₹21.29 Cr ₹38.81 Cr -₹18.77 Cr
Dividends Paid ₹61.41 Cr ₹61.17 Cr ₹56.23 Cr ₹45.92 Cr ₹5.15 Cr
Net Change in Cash -₹1.3 Cr ₹1.45 Cr ₹32.91 Lakh -₹23.97 Lakh -₹4.72 Cr
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25 Q4 FY24 Q3 FY24 Q2 FY24 Q1 FY24
Revenue from Operations ₹60.04 Cr ₹74.34 Cr ₹55.86 Cr ₹49.75 Cr ₹60.27 Cr ₹57.92 Cr ₹52.91 Cr ₹50.78 Cr ₹49.04 Cr ₹39.33 Cr ₹32.28 Cr ₹36.84 Cr
Other Income ₹2.14 Cr ₹2.31 Cr ₹64.92 Cr ₹3.59 Cr ₹2.96 Cr ₹4.37 Cr ₹65.6 Cr ₹1.96 Cr ₹2.04 Cr ₹2.23 Cr ₹47.87 Cr ₹2.63 Cr
Total Income ₹62.18 Cr ₹76.65 Cr ₹120.78 Cr ₹53.34 Cr ₹63.23 Cr ₹62.29 Cr ₹118.52 Cr ₹52.74 Cr ₹51.08 Cr ₹41.55 Cr ₹80.15 Cr ₹39.47 Cr
Cost of Materials Consumed ₹4.04 Cr ₹3.85 Cr ₹2.53 Cr ₹3.45 Cr ₹1.92 Cr ₹1.81 Cr ₹1.41 Cr ₹2.86 Cr ₹3.23 Cr ₹1.58 Cr ₹2.46 Cr ₹1.34 Cr
Purchases of Stock-in-Trade ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Changes in Inventories -₹64.56 Lakh ₹1.05 Cr ₹40.34 Lakh ₹1.74 Cr -₹2.62 Lakh -₹88.26 Lakh ₹70.81 Lakh ₹1.31 Cr -₹1.02 Cr -₹34.46 Lakh -₹58.05 Lakh ₹2.47 Cr
Employee Benefit Expense ₹11.74 Cr ₹10.32 Cr ₹7.55 Cr ₹7.83 Cr ₹6.5 Cr ₹6.56 Cr ₹6.52 Cr ₹7.73 Cr ₹5.55 Cr ₹5.58 Cr ₹5.63 Cr ₹6.27 Cr
Finance Costs ₹56.81 Lakh ₹55.29 Lakh ₹56.41 Lakh ₹59.33 Lakh ₹62.11 Lakh ₹68.7 Lakh ₹67.47 Lakh ₹48.83 Lakh ₹47.53 Lakh ₹36.79 Lakh ₹13.49 Lakh ₹13.05 Lakh
Depreciation & Amortisation ₹3.34 Cr ₹3.44 Cr ₹2.82 Cr ₹2.79 Cr ₹2.75 Cr ₹2.69 Cr ₹2.68 Cr ₹2.5 Cr ₹1.48 Cr ₹2.66 Cr ₹1.86 Cr ₹1.83 Cr
Other Expenses ₹24.69 Cr ₹31.67 Cr ₹22.14 Cr ₹17.15 Cr ₹24.55 Cr ₹24.04 Cr ₹24.68 Cr ₹18.48 Cr ₹17.13 Cr ₹20.83 Cr ₹14.61 Cr ₹15.88 Cr
Total Expenses ₹43.74 Cr ₹50.89 Cr ₹36 Cr ₹33.56 Cr ₹36.32 Cr ₹34.9 Cr ₹36.69 Cr ₹33.37 Cr ₹26.85 Cr ₹30.67 Cr ₹24.12 Cr ₹27.93 Cr
Profit Before Exceptional Items & Tax ₹18.44 Cr ₹25.76 Cr ₹84.78 Cr ₹19.78 Cr ₹26.92 Cr ₹27.39 Cr ₹81.83 Cr ₹19.37 Cr ₹24.23 Cr ₹10.88 Cr ₹56.03 Cr ₹11.55 Cr
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹18.44 Cr ₹25.76 Cr ₹84.78 Cr ₹19.78 Cr ₹26.92 Cr ₹27.39 Cr ₹81.83 Cr ₹19.37 Cr ₹24.23 Cr ₹10.88 Cr ₹56.03 Cr ₹11.55 Cr
Total Tax Expense ₹8.83 Cr ₹3.29 Cr ₹8.72 Cr ₹1.99 Cr ₹3.17 Cr ₹1.3 Cr ₹4.51 Cr ₹1.95 Cr ₹2.94 Cr ₹96.27 Lakh ₹4.32 Cr ₹1.59 Cr
Net Profit ₹67.13 Cr ₹60.13 Cr ₹128.49 Cr ₹61.64 Cr ₹68.45 Cr ₹65.39 Cr ₹121.02 Cr ₹55.82 Cr ₹72.15 Cr ₹61.42 Cr ₹90.68 Cr ₹44.38 Cr
  attributable to Owners -₹33.87 Cr ₹60.13 Cr ₹128.49 Cr ₹61.64 Cr ₹68.45 Cr ₹65.39 Cr ₹121.02 Cr ₹55.82 Cr ₹72.15 Cr ₹61.42 Cr ₹90.68 Cr ₹44.38 Cr
  attributable to NCI ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Other Comprehensive Income -₹100.99 Cr -₹116.97 Cr ₹125.97 Cr ₹4.45 Cr -₹21.32 Cr -₹20.35 Cr -₹31.18 Cr ₹38.54 Cr -₹53.66 Cr -₹14 Cr -₹27.34 Cr ₹35.27 Cr
Total Comprehensive Income -₹33.87 Cr -₹56.84 Cr ₹254.46 Cr ₹66.09 Cr ₹47.13 Cr ₹45.04 Cr ₹89.84 Cr ₹94.36 Cr ₹18.49 Cr ₹47.42 Cr ₹63.34 Cr ₹79.65 Cr
EBITDA (computed) ₹22.35 Cr ₹29.75 Cr ₹88.16 Cr ₹23.17 Cr ₹30.29 Cr ₹30.77 Cr ₹85.19 Cr ₹22.36 Cr ₹26.18 Cr ₹13.91 Cr ₹58.03 Cr ₹13.51 Cr
Basic EPS ₹2.61 ₹2.34 ₹5.00 ₹2.40 ₹2.67 ₹2.55 ₹4.71 ₹2.17 ₹2.81 ₹2.39 ₹3.53 ₹1.73
Diluted EPS ₹2.61 ₹2.34 ₹5.00 ₹2.40 ₹2.67 ₹2.55 ₹4.71 ₹2.17 ₹2.81 ₹2.39 ₹3.53 ₹1.73
Latest 12 quarters shown of 25 on record.
Segment · Q4 FY26 (latest quarter) Revenue Result (PBIT) Assets Liabilities
Active Pharmaceutical Ingredients Business ₹9.83 Cr -₹1.17 Cr ₹180.81 Cr ₹34.8 Cr
Real Estate Business ₹50.21 Cr ₹20.97 Cr ₹515.78 Cr ₹81.48 Cr
Segment · FY 2026 (annual) Revenue Result (PBIT) Assets Liabilities
Active Pharmaceutical Ingredients Business ₹46.59 Cr ₹5.65 Cr - -
Real Estate Business ₹193.4 Cr ₹81.17 Cr - -
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Revenue from Operations ₹231.93 Cr ₹214.36 Cr ₹152.25 Cr ₹123.16 Cr ₹75.97 Cr ₹72.3 Cr ₹73.69 Cr
Other Income ₹72.77 Cr ₹74.51 Cr ₹54.62 Cr ₹64.11 Cr ₹89.09 Cr ₹9.97 Cr ₹93.47 Cr
Total Income ₹304.7 Cr ₹288.87 Cr ₹206.87 Cr ₹187.27 Cr ₹165.06 Cr ₹82.27 Cr ₹167.16 Cr
Cost of Materials Consumed ₹13.88 Cr ₹8 Cr ₹8.62 Cr ₹6.92 Cr ₹8.53 Cr ₹11.77 Cr ₹24.59 Cr
Purchases of Stock-in-Trade ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Changes in Inventories ₹2.55 Cr ₹1.11 Cr ₹52.52 Lakh -₹60.18 Lakh ₹2.46 Cr -₹2.39 Cr ₹6.84 Cr
Employee Benefit Expense ₹37.44 Cr ₹27.31 Cr ₹23.03 Cr ₹24.04 Cr ₹21.47 Cr ₹22.6 Cr ₹20.79 Cr
Finance Costs ₹1.57 Cr ₹1.83 Cr ₹68.72 Lakh ₹15.6 Lakh ₹23.02 Lakh ₹26.64 Lakh ₹27.82 Lakh
Depreciation & Amortisation ₹12.01 Cr ₹10.24 Cr ₹7.46 Cr ₹6.36 Cr ₹4.5 Cr ₹3.91 Cr ₹3.23 Cr
Other Expenses ₹90.37 Cr ₹88.38 Cr ₹63.83 Cr ₹54.79 Cr ₹30.6 Cr ₹29.59 Cr ₹17.75 Cr
Total Expenses ₹157.81 Cr ₹136.88 Cr ₹104.15 Cr ₹91.67 Cr ₹67.79 Cr ₹65.75 Cr ₹73.48 Cr
Profit Before Exceptional Items & Tax ₹146.89 Cr ₹151.99 Cr ₹102.72 Cr ₹95.6 Cr ₹97.28 Cr ₹16.52 Cr ₹93.68 Cr
Exceptional Items ₹0 ₹0 ₹0 -₹10.61 Cr ₹0 ₹0 ₹0
Profit Before Tax ₹146.89 Cr ₹151.99 Cr ₹102.72 Cr ₹85 Cr ₹97.28 Cr ₹16.52 Cr ₹93.68 Cr
Total Tax Expense ₹22.35 Cr ₹10.04 Cr ₹9.83 Cr ₹5.73 Cr ₹11.56 Cr ₹3.15 Cr ₹13.09 Lakh
Net Profit ₹124.54 Cr ₹141.95 Cr ₹92.89 Cr ₹79.27 Cr ₹85.71 Cr ₹13.36 Cr ₹93.55 Cr
Other Comprehensive Income -₹94.65 Cr -₹35.89 Cr -₹56.62 Cr -₹217.91 Cr ₹106.45 Cr ₹345.76 Cr -₹16.68 Cr
Total Comprehensive Income ₹29.89 Cr ₹106.06 Cr ₹36.27 Cr -₹138.64 Cr ₹192.17 Cr ₹359.13 Cr ₹76.87 Cr
EBITDA (computed) ₹160.46 Cr ₹164.06 Cr ₹110.86 Cr ₹102.12 Cr ₹102.01 Cr ₹20.7 Cr ₹97.19 Cr
Basic EPS ₹4.85 ₹5.53 ₹3.62 ₹3.09 ₹3.34 ₹0.52 ₹3.64
Diluted EPS ₹4.85 ₹5.53 ₹3.62 ₹3.09 ₹3.34 ₹0.52 ₹3.64
Metrics FY 2026 FY 2025 FY 2024 FY 2023
Total Assets ₹957.7 Cr ₹1,009.83 Cr ₹945.87 Cr ₹948.14 Cr
Non-current Assets ₹770.86 Cr ₹813.52 Cr ₹812.35 Cr ₹780.99 Cr
Current Assets ₹186.85 Cr ₹196.31 Cr ₹133.52 Cr ₹167.15 Cr
Property, Plant & Equipment ₹169.95 Cr ₹135.33 Cr ₹130.54 Cr ₹131.83 Cr
Inventories ₹52.24 Cr ₹99.39 Cr ₹92.6 Cr ₹88.61 Cr
Trade Receivables ₹30.21 Cr ₹27.89 Cr ₹17.4 Cr ₹22.68 Cr
Cash & Equivalents ₹1.1 Cr ₹2.53 Cr ₹98.6 Lakh ₹82.69 Lakh
Equity (Net Worth) ₹821.46 Cr ₹853.19 Cr ₹808.76 Cr ₹828.99 Cr
Equity Share Capital ₹51.36 Cr ₹51.36 Cr ₹51.36 Cr ₹51.36 Cr
Borrowings (Non-current) ₹6.61 Cr ₹10.67 Cr ₹7.39 Cr ₹0
Borrowings (Current) ₹4.03 Cr ₹3.78 Cr ₹1.76 Cr ₹0
Total Debt (computed) ₹10.64 Cr ₹14.45 Cr ₹9.15 Cr ₹0
Current Liabilities ₹96.31 Cr ₹108.28 Cr ₹89.18 Cr ₹81.04 Cr
Total Liabilities ₹136.25 Cr ₹156.64 Cr ₹137.11 Cr ₹119.16 Cr
The balance sheet became part of the exchange results-filing format in FY2023 - earlier years were not filed and are hidden.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow ₹117.4 Cr ₹81.03 Cr ₹25.33 Cr ₹34.7 Cr -₹21.87 Cr
Investing Cash Flow -₹52.04 Cr -₹21.79 Cr ₹22.6 Cr ₹11.29 Cr ₹22.66 Cr
Financing Cash Flow -₹66.79 Cr -₹57.7 Cr -₹47.77 Cr -₹46.08 Cr -₹5.66 Cr
Capital Expenditure ₹38.25 Cr ₹6.58 Cr ₹1.39 Cr ₹4.68 Lakh ₹1.02 Cr
Free Cash Flow (computed) ₹79.15 Cr ₹74.45 Cr ₹23.94 Cr ₹34.65 Cr -₹22.88 Cr
Dividends Paid ₹61.41 Cr ₹61.17 Cr ₹56.23 Cr ₹45.92 Cr ₹5.15 Cr
Net Change in Cash -₹1.43 Cr ₹1.54 Cr ₹15.91 Lakh -₹9.12 Lakh -₹4.86 Cr
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25 Q4 FY24 Q3 FY24 Q2 FY24 Q1 FY24
Revenue from Operations ₹57.73 Cr ₹72.28 Cr ₹54.04 Cr ₹47.89 Cr ₹58.22 Cr ₹55.97 Cr ₹51.1 Cr ₹49.08 Cr ₹47.51 Cr ₹37.94 Cr ₹31.15 Cr ₹35.65 Cr
Other Income ₹2.41 Cr ₹2.1 Cr ₹64.8 Cr ₹3.46 Cr ₹2.78 Cr ₹4.25 Cr ₹65.59 Cr ₹1.89 Cr ₹1.95 Cr ₹2.21 Cr ₹47.86 Cr ₹2.59 Cr
Total Income ₹60.14 Cr ₹74.38 Cr ₹118.84 Cr ₹51.34 Cr ₹61 Cr ₹60.21 Cr ₹116.69 Cr ₹50.97 Cr ₹49.46 Cr ₹40.15 Cr ₹79.01 Cr ₹38.24 Cr
Cost of Materials Consumed ₹4.04 Cr ₹3.85 Cr ₹2.53 Cr ₹3.45 Cr ₹1.92 Cr ₹1.81 Cr ₹1.41 Cr ₹2.86 Cr ₹3.23 Cr ₹1.58 Cr ₹2.46 Cr ₹1.34 Cr
Purchases of Stock-in-Trade ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Changes in Inventories -₹64.56 Lakh ₹1.05 Cr ₹40.34 Lakh ₹1.74 Cr -₹2.62 Lakh -₹88.26 Lakh ₹70.81 Lakh ₹1.31 Cr -₹1.02 Cr -₹34.46 Lakh -₹58.05 Lakh ₹2.47 Cr
Employee Benefit Expense ₹11.74 Cr ₹10.32 Cr ₹7.55 Cr ₹7.83 Cr ₹6.5 Cr ₹6.56 Cr ₹6.52 Cr ₹7.73 Cr ₹5.55 Cr ₹5.58 Cr ₹5.63 Cr ₹6.27 Cr
Finance Costs ₹36.82 Lakh ₹37.36 Lakh ₹40.32 Lakh ₹42.24 Lakh ₹45.46 Lakh ₹52.23 Lakh ₹51.41 Lakh ₹33.88 Lakh ₹32.8 Lakh ₹26.29 Lakh ₹4.94 Lakh ₹4.7 Lakh
Depreciation & Amortisation ₹3.25 Cr ₹3.34 Cr ₹2.72 Cr ₹2.7 Cr ₹2.66 Cr ₹2.59 Cr ₹2.59 Cr ₹2.41 Cr ₹1.38 Cr ₹2.57 Cr ₹1.77 Cr ₹1.74 Cr
Other Expenses ₹23.05 Cr ₹30 Cr ₹21.04 Cr ₹16.28 Cr ₹23.81 Cr ₹22.76 Cr ₹24.07 Cr ₹17.73 Cr ₹16.37 Cr ₹17.99 Cr ₹14.01 Cr ₹15.46 Cr
Total Expenses ₹41.8 Cr ₹48.94 Cr ₹34.64 Cr ₹32.43 Cr ₹35.32 Cr ₹33.36 Cr ₹35.82 Cr ₹32.38 Cr ₹25.85 Cr ₹27.63 Cr ₹23.34 Cr ₹27.33 Cr
Profit Before Exceptional Items & Tax ₹18.34 Cr ₹25.44 Cr ₹84.19 Cr ₹18.92 Cr ₹25.68 Cr ₹26.85 Cr ₹80.87 Cr ₹18.59 Cr ₹23.61 Cr ₹12.53 Cr ₹55.66 Cr ₹10.91 Cr
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹18.34 Cr ₹25.44 Cr ₹84.19 Cr ₹18.92 Cr ₹25.68 Cr ₹26.85 Cr ₹80.87 Cr ₹18.59 Cr ₹23.61 Cr ₹12.53 Cr ₹55.66 Cr ₹10.91 Cr
Total Tax Expense ₹8.81 Cr ₹3.19 Cr ₹8.56 Cr ₹1.8 Cr ₹2.85 Cr ₹1.16 Cr ₹4.27 Cr ₹1.76 Cr ₹2.93 Cr ₹1.24 Cr ₹4.23 Cr ₹1.43 Cr
Net Profit ₹9.53 Cr ₹22.26 Cr ₹75.63 Cr ₹17.12 Cr ₹22.83 Cr ₹25.69 Cr ₹76.6 Cr ₹16.84 Cr ₹20.68 Cr ₹11.29 Cr ₹51.43 Cr ₹9.48 Cr
Other Comprehensive Income -₹104.29 Cr -₹119.24 Cr ₹124.64 Cr ₹4.24 Cr -₹22.9 Cr -₹20.93 Cr -₹31.55 Cr ₹39.49 Cr -₹50.37 Cr -₹14.29 Cr -₹27.5 Cr ₹35.54 Cr
Total Comprehensive Income -₹94.76 Cr -₹96.98 Cr ₹200.27 Cr ₹21.36 Cr -₹7.38 Lakh ₹4.76 Cr ₹45.05 Cr ₹56.33 Cr -₹29.69 Cr -₹3 Cr ₹23.94 Cr ₹45.02 Cr
EBITDA (computed) ₹21.96 Cr ₹29.16 Cr ₹87.32 Cr ₹22.04 Cr ₹28.79 Cr ₹29.97 Cr ₹83.97 Cr ₹21.34 Cr ₹25.33 Cr ₹15.35 Cr ₹57.48 Cr ₹12.7 Cr
Basic EPS ₹0.37 ₹0.87 ₹2.95 ₹0.67 ₹0.89 ₹1.00 ₹2.98 ₹0.66 ₹0.81 ₹0.44 ₹2.00 ₹0.37
Diluted EPS ₹0.37 ₹0.87 ₹2.95 ₹0.67 ₹0.89 ₹1.00 ₹2.98 ₹0.66 ₹0.81 ₹0.44 ₹2.00 ₹0.37
Latest 12 quarters shown of 25 on record.
Segment · Q4 FY26 (latest quarter) Revenue Result (PBIT) Assets Liabilities
Active Pharmaceutical Ingredients Business ₹9.83 Cr -₹1.17 Cr ₹180.81 Cr ₹34.8 Cr
Real Estate Business ₹47.9 Cr ₹20.67 Cr ₹501.65 Cr ₹71.9 Cr
Segment · FY 2026 (annual) Revenue Result (PBIT) Assets Liabilities
Active Pharmaceutical Ingredients Business ₹46.59 Cr ₹5.65 Cr - -
Real Estate Business ₹185.35 Cr ₹78.59 Cr - -
Want more history and ratios?
You're viewing the latest exchange-filed financials for Alembic Limited. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Shareholding Pattern of Alembic Limited

As per the shareholding pattern filed with NSE for the quarter ended Mar 2026, promoters hold 70.88%, foreign institutional investors hold 1.25%, domestic institutional investors hold 0.05%, retail and other public shareholders hold 27.82% of Alembic Limited. The company had 102,008 shareholders on record.

Promoters: 70.88%DII (Domestic Institutional): 0.05%FII (Foreign Institutional): 1.25%Retail & Others: 27.82%
Mar 2026
QUARTER
70.88% Promoters
0.05% DII (Domestic Institutional)
1.25% FII (Foreign Institutional)
27.82% Retail & Others
Promoter holding - history
Now 70.88% · Mar 2026High 70.88% · Mar 2021Low 63.53% · Sep 2017
62%64.5%67%69.5%72%Dec 2015May 2018Sep 2020Mar 2023Sep 2025Dec 2015: 64.18%Mar 2016: 64.46%Jun 2016: 64.46%Sep 2016: 64.97%Dec 2016: 65.25%Mar 2017: 65.77%Jun 2017: 65.77%Sep 2017: 63.53%Dec 2017: 63.71%Mar 2018: 63.71%May 2018: 63.54%Jun 2018: 63.54%Sep 2018: 63.54%Dec 2018: 64.01%Mar 2019: 64.57%Jun 2019: 65.22%Sep 2019: 66.31%Dec 2019: 67.09%Mar 2020: 67.62%Jun 2020: 69.57%Sep 2020: 70.41%Dec 2020: 70.41%Mar 2021: 70.88%Jun 2021: 70.88%Sep 2021: 70.88%Dec 2021: 70.88%Mar 2022: 70.88%Jun 2022: 70.88%Sep 2022: 70.88%Dec 2022: 70.88%Mar 2023: 70.88%Jun 2023: 70.88%Sep 2023: 70.88%Dec 2023: 70.88%Mar 2024: 70.88%Jun 2024: 70.88%Sep 2024: 70.88%Dec 2024: 70.88%Mar 2025: 70.88%Jun 2025: 70.88%Sep 2025: 70.88%Dec 2025: 70.88%Mar 2026: 70.88%70.88%63.53%70.88%
Shareholding trend - last 6 quarters
Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Promoters70.88%70.88%70.88%70.88%70.88%70.88%
Public29.12%29.12%29.12%29.12%29.12%29.12%
Shareholding history - year on year (as at 31 March)
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016
Promoters70.88%70.88%70.88%70.88%70.88%70.88%67.62%64.57%63.71%65.77%64.46%
Public29.12%29.12%29.12%29.12%29.12%29.12%32.38%35.43%36.29%34.23%35.54%
Promoter change (YoY, %pts)+0.00+0.00+0.00+0.00+0.00+3.26+3.05+0.86-2.06+1.31-

Board & Governance of Alembic Limited

As per the corporate governance filing with NSE for the quarter ended 31-MAR-2026, the board of Alembic Limited has 8 directors - 4 independent and 1 executive. The board is chaired by Chirayu Ramanbhai Amin.

DirectorPositionOn board sinceListed boards
Chirayu Ramanbhai Amin Non-Executive - Non Independent Director · Chairperson 1967-08-20 3
Malika Chirayu Amin Non-Executive - Non Independent Director 1988-07-02 1
Udit Chirayu Amin Executive Director · MD 2013-04-24 2
Rati Ajay Desai Non-Executive - Independent Director 2019-08-13 1
Girish Srinivasiah Hirode Non-Executive - Independent Director 2023-08-10 1
Mayurdhvaj Dilipsinh Jadeja Non-Executive - Independent Director 2025-02-07 1
Sanjeev Virendra Shah Non-Executive - Independent Director 2025-02-07 1
Jain Parkash Non-Executive - Non Independent Director 2025-02-08 1
Board Committees
CommitteeMembers
Audit Committee Rati Ajay Desai (Chairperson), Mayurdhvaj Dilipsinh Jadeja, Sanjeev Virendra Shah
Nomination and remuneration committee Rati Ajay Desai (Chairperson), Girish Srinivasiah Hirode, Mayurdhvaj Dilipsinh Jadeja, Sanjeev Virendra Shah
Stakeholders Relationship Committee Mayurdhvaj Dilipsinh Jadeja (Chairperson), Udit Chirayu Amin, Sanjeev Virendra Shah
Risk Management Committee Rati Ajay Desai (Chairperson), Jain Parkash, Avaneeshnath Sharma
Corporate Social Responsibility Committee Malika Chirayu Amin (Chairperson), Mayurdhvaj Dilipsinh Jadeja, Rati Ajay Desai

Group Structure of Alembic Limited

Alembic Limited has 1 subsidiary company and 1 associated company. This group structure data is as of FY 2023. The corporate group structure reflects Alembic Limited's business expansion strategy and organizational complexity.

1
Subsidiary companies
1
Associated companies
Key Subsidiaries
Company Name CIN Shares Held
Alembic City Limited U70100GJ1994PLC021552 -

Showing major subsidiaries. Total: 1.

Charges & Borrowings of Alembic Limited

Open charges
₹67 Cr
Satisfied charges
₹446.2 Cr
Breakdown by lending institutions
Others₹67.00 Cr
Latest charge details
DateLenderAmountStatus
22 Sep 2023 Others ₹31 Cr Open
08 May 2006 Others ₹36 Cr Open
25 Sep 2009 Idbi Trusteeship Services Limited ₹25 Cr Satisfied
11 Aug 2009 Idbi Trusteeship Services Limited ₹25 Cr Satisfied
13 Sep 2007 Idbi Trusteeship Services Ltd ₹75 Cr Satisfied

Total charge records: 21 View all charges

Employees and EPFO Compliance at Alembic Limited

Alembic Limited has a workforce of 287 employees as of Apr 07, 2024.

Employee count
287
Active EPFO establishments
1
Employee growth
-4.65%
Premium access

Employee and EPFO history for Alembic Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Alembic Limited

Premium access

GST registrations and filing compliance for Alembic Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Alembic Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Alembic Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Alembic Limited

Premium access

MSME payment history for Alembic Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Alembic Limited

Premium access

Corporate group structure for Alembic Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Alembic Limited

Premium access

MCA filings and documents for Alembic Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Alembic Limited

Activity
12 Aug 2025
Alembic Limited last Annual general meeting of members was held on 12 Aug 2025 as per latest MCA records.
Activity
31 Mar 2025
Alembic Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Directors
08 Feb 2025
Jain Parkash was appointed as a Director on 08 Feb 2025 & has been associated with this company since 1 year 6 months.
Directors
07 Feb 2025
Sanjeev Virendra Shah was appointed as a Director on 07 Feb 2025 & has been associated with this company since 1 year 6 months.
Directors
07 Feb 2025
Mayurdhvaj Dilipsinh Jadeja was appointed as a Director on 07 Feb 2025 & has been associated with this company since 1 year 6 months.
Charges
22 Sep 2023
A charge with Others amounted to Rs. 31.00 Cr with Charge ID 100795632 was registered on 22 Sep 2023.

Recent News on Alembic Limited

Frequently Asked Questions about Alembic Limited

Alembic Limited is an active public limited company in the pharma sector based in Baroda, Gujarat, India. It was incorporated on 30 July 1907 (119+ years old) and is registered under CIN L26100GJ1907PLC000033. Listed on BSE: 506235 and NSE: ALEMBICLTD. The company has 287 employees.

Alembic Limited reported revenue of ₹239.99 Cr for FY 2026 (up 8.16% YoY) based on consolidated NSE filings.

The current directors of Alembic Limited are:

The primary industry of Alembic Limited is pharma. The company specifically operates in api manufacturers. The company is currently active in this sector.

Yes. Alembic Limited is listed on both BSE (code: 506235) and NSE (symbol: ALEMBICLTD).

Alembic Limited can be reached at the registered office: Alembic Road, Baroda, Gujarat, India – 390003, or through the website alembiclimited.com.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available